Paratek Pharmaceuticals
PRTK
#9222
Rank
A$0.17 B
Marketcap
A$3.10
Share price
0.00%
Change (1 day)
4.50%
Change (1 year)

Earnings for Paratek Pharmaceuticals (PRTK)

Earnings in 2023 (TTM): -A$66.28 Million

According to Paratek Pharmaceuticals 's latest financial reports the company's current earnings are A$0.16 Billion. In 2022 the company made an earning of -A$63.18 Million a decrease over its 2021 earnings that were of -A$57.18 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Paratek Pharmaceuticals from 2004 to 2023

Annual earnings

Year Earnings Change
2023 (TTM) -A$66.28 Million4.91%
2022 -A$63.18 Million10.5%
2021 -A$57.18 Million-46.16%
2020 -A$0.11 Billion-31.93%
2019 -A$0.16 Billion11.12%
2018 -A$0.15 Billion21.19%
2017 -A$0.12 Billion-23.22%
2016 -A$0.16 Billion54.68%
2015 -A$97.56 Million309.5%
2014 -A$23.83 Million-29.88%
2013 -A$33.98 Million
2011 -A$5.24 Million-59.18%
2010 -A$12.84 Million-53.53%
2009 -A$27.63 Million-161.93%
2008 A$44.6 M-187.43%
2007 -A$51.02 Million11.93%
2006 -A$45.58 Million31.69%
2005 -A$34.61 Million32.4%
2004 -A$26.14 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Ultragenyx Pharmaceutical
RARE
-A$0.75 Billion 1,127.66%๐Ÿ‡บ๐Ÿ‡ธ USA
Spectrum Pharmaceuticals
SPPI
-A$86.13 Million 41.58%๐Ÿ‡บ๐Ÿ‡ธ USA
Agenus
AGEN
A$28.75 M-147.28%๐Ÿ‡บ๐Ÿ‡ธ USA